Loading
Loading…
Loading…
Tender Value
₹96,628
EMD Value
Exempted
Closing Date
5 Oct 2026, 6:00 pm
Published by the portal on this tender, for queries and grievance redressal.
DRUG AND PHARMACEUTICALS
9808642
GEM/2026/B/7963333
Two Packet Bid
TAB METOPROLOL XL 25 MG
Faridabad, Haryana
Total value wise evaluation
BOQ
8 documents required · 8 mandatory
2 yrs
₹31
₹3 L
80%
Exempted
Yes
14 Sept 2026
14 Sept 2026
6 Oct 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | LIGNOCAINE JELLY 2 PERCENT | AS PER ATC | 6 | Tube | SMO56ASP | 15 |
| 2 | SYP IBUPROFEN 100MG PER 5ML | AS PER ATC | 30 | BOTT | SMO56ASP | 15 |
| 3 | INJ ADRENALINE TARTRATE | AS PER ATC | 12 | Amp Vail | SMO56ASP | 15 |
| 4 | TAB PHENIRAMINE MALEATE 25 MG | AS PER ATC | 90 | NO | SMO56ASP | 15 |
| 5 | INJ DIAZEPAM 10MG 2ML | AS PER ATC | 3 | Amp Vail | SMO56ASP | 15 |
| 6 | TABLET CHLORZOXAZONE 500 MG PLUS DICLOFENAC SODIUM 50 MG PLUS PARACETAMOL | AS PER ATC | 1,200 | NO | SMO56ASP | 15 |
| 7 | TAB METHOTREXATE 5 MG | AS PER ATC | 90 | NO | SMO56ASP | 15 |
| 8 | TAB METOPROLOL XL 25 MG | AS PER ATC | 900 | NO | SMO56ASP | 15 |
| 9 | TAB ASPRIN 75 MG | AS PER ATC | 1,200 | NO | SMO56ASP | 15 |
| 10 | CLINDAMYCIN PHOSPHATE 1 PERCENT GEL | AS PER ATC | 20 | Tube | SMO56ASP | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9808642.pdf
GEM_BID • 0.41 MB
atc_2026-08-26-11-34-27_bdd181d7bd40a1df4b0c67f09a9daab7.pdf
BOQ • 0.17 MB
final_boq_25_aug_2026_2026-08-26-11-34-27_37319946f4da03dbf0e580d69a39ead8.csv
BOQ • 0.01 MB
ATC_123bb2b2-6a25-4d6b-9b961787727352485_SMO56ASP.pdf
GEM_OTHER • 0.17 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .